BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 34060656)

  • 1. Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Lan YP; Qi B; Yin L; Zhang LX; Liu W
    J Dermatol; 2021 Sep; 48(9):1394-1400. PubMed ID: 34060656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin as a diagnostic indicator for systemic bacterial infections in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Wang Q; Tian XB; Liu W; Zhang LX
    J Dermatol; 2018 Aug; 45(8):989-993. PubMed ID: 29897140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Zhang Z; Yu K; Jiang Z; Liu O; Wan C; Wu H; Cao X
    J Dermatol; 2023 Apr; 50(4):518-524. PubMed ID: 36478458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.
    Suo H; Jiang B; Sun X; Dong J; Alamgir M; Guan X; Su H; Liu Y; Xia Y; Zhou N; Feng A; Tao J
    Dermatology; 2022; 238(4):736-744. PubMed ID: 34875648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Correlation of Neutrophil-Lymphocyte Ratio and Eosinophil Count with SCORTEN in SJS/TEN.
    Primisawitri PP; Mawardi P
    Clin Cosmet Investig Dermatol; 2022; 15():547-556. PubMed ID: 35387203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
    Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
    JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated endocan levels and its association with clinical severity in Stevens-Johnson Syndrome and toxic epidermal necrolysis.
    Syed D; Iqbal O; Mosier M; Mitchell R; Hoppensteadt D; Bouchard C; Fareed J; Gamelli R
    Int Angiol; 2015 Oct; 34(5):483-8. PubMed ID: 25394955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nationwide epidemiological survey of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan, 2016-2018.
    Sunaga Y; Kurosawa M; Ochiai H; Watanabe H; Sueki H; Azukizawa H; Asada H; Watanabe Y; Yamaguchi Y; Aihara M; Mizukawa Y; Ohyama M; Hama N; Abe R; Hashizume H; Nakajima S; Nomura T; Kabashima K; Tohyama M; Takahashi H; Mieno H; Ueta M; Sotozono C; Niihara H; Morita E; Kokaze A
    J Dermatol Sci; 2020 Dec; 100(3):175-182. PubMed ID: 33046331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Torres-Navarro I; Briz-Redón Á; Botella-Casas G; Sahuquillo-Torralba A; Calle-Andrino A; de Unamuno-Bustos B; Piqueras-García J; Roca Ginés J; Magdaleno Tapial J; Alegre de Miquel V; Botella-Estrada R
    J Dermatol; 2020 Oct; 47(10):1182-1186. PubMed ID: 32856355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Duplisea MJ; Roberson ML; Chrisco L; Strassle PD; Williams FN; Ziemer CM
    J Am Acad Dermatol; 2021 Oct; 85(4):873-877. PubMed ID: 33940101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of histologic features of toxic epidermal necrolysis.
    Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
    J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RDW-SD and PCT Are Potential Prognostic Factors for In-hospital Death in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
    Zhang L; Lan Y; Qi B; Shuai P; Hou Q; Liu W; Wang Q
    Allergy Asthma Immunol Res; 2023 Nov; 15(6):812-824. PubMed ID: 37957797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cohort study of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in China: evaluation of risk models and new predictor of pulmonary consolidation on computed tomography.
    Shou Y; Yang L; Yang Y; Zhu X; Li F; Yin B; Zheng Y; Xu J
    Front Med; 2021 Aug; 15(4):585-593. PubMed ID: 33644844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutrophil-to-lymphocyte Ratio, Platelet-to-lymphocyte Ratio, C-reactive Protein to Albumin Ratio, and Albumin to Fibrinogen Ratio in Axial Spondyloarthritis: A Monocentric Study.
    Slouma M; Rahmouni S; Dhahri R; Gharsallah I; Metoui L; Louzir B
    Curr Rheumatol Rev; 2021; 17(3):312-317. PubMed ID: 33357182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of intravenous immunoglobulin and corticosteroid in the treatment of toxic epidermal necrolysis and Stevens-Johnson syndrome: a retrospective comparative study in China.
    Yang Y; Xu J; Li F; Zhu X
    Int J Dermatol; 2009 Oct; 48(10):1122-8. PubMed ID: 19775409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective study of 213 cases of Stevens-Johnson syndrome and toxic epidermal necrolysis from China.
    Yang L; Shou YH; Li F; Zhu XH; Yang YS; Xu JH
    Burns; 2020 Jun; 46(4):959-969. PubMed ID: 31898979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis.
    Bansal S; Garg VK; Sardana K; Sarkar R
    Int J Dermatol; 2015 Jan; 54(1):e18-26. PubMed ID: 25534407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose intravenous immunoglobulins in the treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis in Chinese patients: a retrospective study of 82 cases.
    Chen J; Wang B; Zeng Y; Xu H
    Eur J Dermatol; 2010; 20(6):743-7. PubMed ID: 20952352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in 87 Japanese patients--Treatment and outcome.
    Yamane Y; Matsukura S; Watanabe Y; Yamaguchi Y; Nakamura K; Kambara T; Ikezawa Z; Aihara M
    Allergol Int; 2016 Jan; 65(1):74-81. PubMed ID: 26666483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.